Edinburgh, Scotland
Joined August 2017
- Tweets31
- Following164
- Followers73
- Likes113
Research assistant/lab manager position open in Adrian Bird’s lab. Come and join us!
elxw.fa.em3.oraclecloud.com/…
Matthew Lyst retweeted
Come and join us for a fully funded PhD project studying the molecular basis of Bohring-Opitz Syndrome. Interested in the aetiology of chromatinopathies associated with perturbed polycomb function? Please apply👇. Informal inquires welcome.
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
Matthew Lyst retweeted
What things are you doing in your lab to reduce plastic waste? Take a look at what the Bird lab is doing. #sustainabilityinscience
Matthew Lyst retweeted
Do [CA]n (CA repeats) mediate MeCP2 function? Follow this thread to know more 🧵
Our recently published critique ⚠️ of a @ScienceMagazine article with open, constructive and fair peer review in @LSAjournal
🙏 to all co-authors @WTcell @sk_kriaucionis
life-science-alliance.org/co…
Matthew Lyst retweeted
Our lab is hiring! We are looking for a (part-time) research technician, ideally someone with experience in cell culture & biochemistry, who is willing to learn more about proteomics. Please apply here: elxw.fa.em3.oraclecloud.com/…
Matthew Lyst retweeted
🔬🥼PhD Alert👩🔬👨🔬. Interested in understanding the mechanisms of neurodevelopmental disorders caused by perturbed chromatin regulation? Come and join us in Edinburgh for a fully funded SIDB #PhD. edinburghneuroscience.ed.ac.…
Closing date 16 th January. Any queries please get in touch.
Matthew Lyst retweeted
If you love #RNA this #Job might be for you - we are is inviting applications for a Postdoctoral Researcher to join Dioscuri Centre for RNA-Protein Interactions in Human Health and Disease at #IIMCB, Warsaw, Poland
@gmichlew
More: bit.ly/3wF1mEi
Deadline: June 21, 2021
I, for one, welcome our new AI overlords.
A machine-learning model can be used to predict the future “impact” of research published in scientific literature, according to a @NatureBiotech paper. The model could aid in the construction of diversified, impact-optimized funding portfolios. go.nature.com/2SZkRbZ
New paper from Adrian Bird’s lab: MeCP2 – which is mutated in Rett syndrome - was discovered as a methyl-CpG binding protein, but it can also bind to DNA containing methylated CpA dinucleotides. Which of these binding sites is most important?
Mice where the DNA binding domain of MeCP2 is replaced by the DNA binding domain of a related protein (MBD2 - which can bind to mCpG but not to mCpA) develop neurological problems and die prematurely. So mCA is likely the key binding site for MeCP2.
dlvr.it/RsPwpH
Matthew Lyst retweeted
NYT has a great profile of a titan in the Rett syndrome community, Monica Coenraads, and other heros for rare diseases like her. The examples these folks set should give all us researchers a kick in the butt to take our work ethic to the next level!
nytimes.com/2020/07/07/healt…
Neuronal non-CG methylation is an essential target for MeCP2 function biorxiv.org/content/10.1101/…
Matthew Lyst retweeted
Great work from Adrian Bird's lab revealing a role for Sall4 binding to AT-rich DNA in controlling cell fate. Nelleke Spruijt in our lab did interaction proteomics (a long time ago! :)) for this study.
biorxiv.org/content/10.1101/…
Matthew Lyst retweeted
I’m excited to present our new preprint on meiotic kinetochore composition and assembly. Great work by Wera, Nadine, Eris and Vasso with fantastic collaborators Krishna Sarangapani, Chip Asbury, Christos Spanos and Juri Rappsilber. biorxiv.org/content/10.1101/…